Medicare Enrolled
Dr. James Belarmino, MD
Urology Physician · Latham, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Belarmino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Belarmino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Belarmino
Dr. James Belarmino is an urology physician in Latham, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Belarmino performed 877 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Belarmino received a total of $13,725 from 53 pharmaceutical and/or device companies across 352 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Belarmino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ 877 Medicare services
$13,725 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗877
Medicare services
Bottom 42% in NY for urology physician
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $89 | $210 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
113 | $174 | $754 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $58 | $141 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
102 | $7 | $50 |
| PSA test (prostate cancer screening) | 75 | $18 | $51 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $111 | $324 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
55 | $38 | $101 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
39 | $8 | $20 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
31 | $184 | $800 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
31 | $45 | $338 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $128 | $283 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $19 | $36 |
| Cystourethrogram An X-ray imaging procedure performed by injecting contrast material through the bladder and urethra to visualize the urinary tract. |
15 | $24 | $135 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $157 | $411 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $90 | $205 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $228 | $750 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
13 | $3 | $12 |
| New patient office visit, complex (60-74 min) | 12 | $140 | $405 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
20.5% medium
78.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,725
Total received (2018-2024)
Avg $1,961/year across 7 years
Top 15% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
352
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,431
2023
$2,471
2022
$1,788
2021
$2,109
2020
$593
2019
$3,287
2018
$1,046
Payments by company (2024)
Teleflex LLC
$707
Axonics, Inc.
$352
Astellas Pharma US Inc
$333
Merck Sharp & Dohme LLC
$202
Sumitomo Pharma America, Inc.
$189
PFIZER INC.
$109
Myriad Genetic Laboratories, Inc.
$109
Tolmar, Inc.
$93
ABBVIE INC.
$61
Boston Scientific Corporation
$58
Medtronic, Inc.
$55
Olympus America Inc.
$34
Novartis Pharmaceuticals Corporation
$26
UROGEN PHARMA, INC.
$24
Janssen Biotech, Inc.
$22
ACCORD HEALTHCARE, INC.
$21
Laborie Medical Technologies Corp.
$20
COLOPLAST CORP
$17
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$3,537
Intuitive Surgical, Inc.
$2,520
Astellas Pharma US Inc
$1,873
Boston Scientific Corporation
$743
Axonics, Inc.
$450
PFIZER INC.
$386
Sumitomo Pharma America, Inc.
$350
Merck Sharp & Dohme LLC
$333
UROVANT SCIENCES INC
$331
NeoTract Inc.
$261
Olympus America Inc.
$251
ABBVIE INC.
$237
AbbVie Inc.
$207
Endo Pharmaceuticals Inc.
$161
Coloplast Corp
$142
Janssen Biotech, Inc.
$137
Allergan, Inc.
$132
Avadel Specialty Pharmaceuticals, LLC
$132
Tolmar, Inc.
$131
Axonics Modulation Technologies, Inc.
$125
Myriad Genetic Laboratories, Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$107
Janssen Products, LP
$99
Merck Sharp & Dohme Corporation
$97
Hollister Incorporated
$75
Alnylam Pharmaceuticals Inc.
$69
Medtronic, Inc.
$55
AbbVie, Inc.
$55
Accord Healthcare, Inc.
$53
Allergan Inc.
$52
180 Medical, Inc.
$38
COLOPLAST CORP
$37
Amgen Inc.
$37
Antares Pharma, Inc.
$32
C. R. Bard, Inc. & Subsidiaries
$31
Pharmacyclics LLC, an AbbVie Company
$26
Novartis Pharmaceuticals Corporation
$26
TherapeuticsMD, Inc.
$25
UROGEN PHARMA, INC.
$24
Vanda Pharmaceuticals Inc.
$24
ACCORD HEALTHCARE, INC.
$21
Novo Nordisk Inc
$21
Laborie Medical Technologies Corp.
$20
Myovant Sciences Inc.
$20
Medtronic USA, Inc.
$19
Ethicon US, LLC
$17
ROCHESTER MEDICAL CORPORATION
$16
Siemens Medical Solutions USA, Inc.
$15
Covidien LP
$15
Rochester Medical Corporation
$13
C. R. BARD, INC. & SUBSIDIARIES
$13
C. R. BARD FOUNDATION, INC.
$13
GlaxoSmithKline, LLC.
$12
Top 3 companies account for 57.8% of all-time payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AMS 700 · ANNOVERA · ANORO ELLIPTA · AVEED · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CONTINENCE CARE · CURE CATHETER · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GIVLAARI · GREENLIGHT · Hetlioz · IMBRUVICA · IMVEXXY · INTERSTIM · JELMYTO · Juniper · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · Noctiva · ONLI · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otezla · PLUVICTO · PREMARIN · PROLARIS · Rezum Generator · Rybelsus · SPEEDICATH · Signia · SpeediCath · URETERO-RENO FIBERSCOPE · UROLIFT · UroLift · UroLift System · UroPass · VAPRO · VESICARE · VISTASEAL · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
52
County median income
$83,149
Nearest hospital to ZIP centroid (approximate)
ALBANY MEDICAL CENTER HOSPITAL
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Belarmino is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Belarmino experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Belarmino performed 126 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Belarmino receive payments from pharmaceutical companies?
Yes. Dr. Belarmino received a total of $13,725 from 53 companies across 352 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Belarmino's costs compare to other urology physicians in Latham?
Dr. Belarmino's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Belarmino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Latham
Browse urology physicians in Latham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology